Hannu T. Aro

Corporate Officer/Principal bei University of Turku

Consumer Services

Health Technology

Profil

Hannu T.
Aro is currently a Professor at the University of Turku.
Previously, he worked as a Director at BonAlive Biomaterials Oy and as a Principal at The Johns Hopkins University.

Aktive Positionen von Hannu T. Aro

Unternehmen	Position	Beginn
University of Turku	Corporate Officer/Principal	13.09.2010

Alle aktiven Positionen von Hannu T. Aro

Ehemalige bekannte Positionen von Hannu T. Aro

Unternehmen	Position	Ende
The Johns Hopkins University	Corporate Officer/Principal	-
BonAlive Biomaterials Oy BonAlive Biomaterials Oy Medical SpecialtiesHealth Technology BonAlive Biomaterials Oy is a holding company that provides solutions to heal patients with bone defects. It develops synthetic biomaterial solutions for the treatment of chronically infected bone. Their products include BonAlive granules and BonAlive putty, which are osteostimulative; BonAlive granules, which inhibits bacterial growth and act as tool for bone cavity filling in the treatment of chronic osteomyelitis; and BonAlive plates, which have been designed for repair of orbital floor trauma. The company was founded by Fredrik Viktor Ollila on November 13, 2009 and is headquartered in Turku, Finland.	Direktor/Vorstandsmitglied	-

Sehen Sie sich die Erfahrung von Hannu T. Aro im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Hannu T. Aro im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	1
BonAlive Biomaterials Oy BonAlive Biomaterials Oy Medical SpecialtiesHealth Technology BonAlive Biomaterials Oy is a holding company that provides solutions to heal patients with bone defects. It develops synthetic biomaterial solutions for the treatment of chronically infected bone. Their products include BonAlive granules and BonAlive putty, which are osteostimulative; BonAlive granules, which inhibits bacterial growth and act as tool for bone cavity filling in the treatment of chronic osteomyelitis; and BonAlive plates, which have been designed for repair of orbital floor trauma. The company was founded by Fredrik Viktor Ollila on November 13, 2009 and is headquartered in Turku, Finland.	Health Technology